DIABETES MELLITUS: AN INCISIVE REVIEW
Keywords:
Diabetes Mellitus, Types, Pathophysiology, Pathogenesis, ManagementAbstract
Diabetes mellitus is an endocrinologicalor metabolic order with an expanding worldwide pervasiveness and rate. Diabetes mellitus (DM), or just diabetes, is a gathering of metabolic ailments in which a man has high glucose, either in light of the fact that the body does not create enough insulin, or in light of the fact that cells don't react to the insulin that is created. This high glucose creates the established side effects of polyuria (visit pee), polydipsia (expanded thirst) and polyphagia (expanded craving). Expectedly, diabetes has been separated into three Types in particular: Type 1 DM or insulin-subordinate diabetes mellitus (IDDM) in which body fails to deliver insulin, and in a matter of seconds requires the individual to infuse insulin or wear an insulin pump. This is likewise named as "adolescent diabetes". Type 2 DM or non-insulin-subordinate diabetes mellitus (NIDDM), comes about because of insulin resistance, a condition in which cells neglect to utilize insulin legitimately, with or without a flat out insulin lack. This Type was beforehand alluded to as or "grown-up onset diabetes". The third fundamental Type is gestational diabetes which happens when ladies without a past history of diabetes build up a high blood glucose level amid her pregnancy. It might go before advancement of Type 2 DM.
Downloads
References
Kumar PJ, Clark M. Textbook of Clinical Medicine. Pub: Saunders (London): 1099-1121, (2002).
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care.1997; 20: 1183-1197.
Beverley B, Eschewed E. The diagnosis and classification of diabetes and impaired glucose tolerance. In: Textbook of Diabetes 1 Ed: John CPickup and Gareth Williams Third edition; Chapter 2, 2.1-2.11, (2003).
Lindberg G, Lindblad U, Melander A. Sulfonylureas for treating type 2 diabetes mellitus. Cochrane Database Systemic Reviews volume 3, 2004.
Arora S, Ojha SK, Vohora D. Characterization of Streptozotocin induced diabetes mellitus in Swiss Albino mice. Glo J of Pharmacol.2009; 3(2):81-84.
Jothivel N. Ponnusamy SP. Appachi M. Antidiabetic activities of methanol leaf extract of Costuspic-tusD. Don in alloxan-induced diabetic rats.J of health sci.2007; 53(6): 655-663.
Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications, estimates and projections to the year 2010. Diabetic Med 1997; 14:1-85.
King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025. Prevalence, numerical estimate and projections. Diabetes Care 1998; 21: 1414-1431.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes.1979; 18: 1039-1057.
World Health Organization Expert Committee on Diabetes Mellitus. Second WHO Technical Report, Series 646. Geneva: World Health Organization 1980.
World Health Organization Study Group. Diabetes Mellitus: WHO Technical Report, Series 727. Geneva: World Health Organization, 1985.
World Health Organization Consultation. Definition,Diagnosis and Classification of Diabetes Mellitus and its Complications, Part 1: Diagnosis and classification of Diabetes Mellitus. Report of a WHO Consultation. Geneva: World Health Organization, 1999.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 Diabetes Mellitus: A Review of Current Trends. Oman Med J. 2012; 27(4):269–273.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimate for the year 2000 and projections for 2030. Diabetes Care.2004;127(5):1047-1053.
Robertson RP. Antagonist: diabetes and insulin resistance–philosophy, science, and the multiplier hypothesis. J Lab Clin Med.1995;125(5):560-564.
Rang HP, Dale MM. Pharmacology, Sixth Edition, and Churchill Livingstone. “The Endocrine Pan-creas and Control of Blood Glucose.2008:397-409.
Sims-Robinson C, Kim B, Rosko A. How does diabetes accelerate Alzheimer disease pathology.Nat Rev Neurol.2010;6(10):551-559.
Al Homsi MF, Lukic ML. An Update on the pathogenesis of Diabetes Mellitus, Department of Pathology and Medical Microbiology (Immunology Unit)Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.1992.
Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada Analysis of the roles of CD4+ T cells in autoimmune diabetes of NOD mice using transfer to NOD male mice. Eur. J. Immunol.1992; 22:2387-2393.
Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ER. A T-cell dormant state in the autoimmune process of non-obese diabetic mice treated with complete Freund's adjuvant. Proc. Natl. Acad. Sci. USA.1992; 89:3927-3931.
Fowell D, Mcknight AI, Powrie F, Dyke R, Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev.1991; 123:37-64.
Kolb-bachofen V, Epstein SQ, Kiesel U, Kolb H. Low dose streptozocin induced diabetes in mice. Electron microscopy reveals single-cells insulitis before diabetes onset. Diabetes.1988; 37:21-27.
Mandrup-poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgensen DW, Bendtzen K, Nielsen JH, Nerup J. Islet cytotoxicity of interleukin-l. Influence of culture conditions and islet donor characteristics. Diabetes, 1987; 36:641-647.
Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, LiewFY.Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun.1991; 178:913-920.
Defronzo RA, Ferrannini E. The Triumvirate: Beta Cell, Muscle, Liver. A Collusion Responsible for NIDDM. Diabetes.1988; 37:667-687.
Holt GI. Diagnosis, epidemiology and pathogenesis of diabetes mellitus an update for Psychiatrists. Br. J. Psychiatry.2004; 184:55- 63.
Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengård J, Kesäniemi YA. Concordance for Type 1 (insulin dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in population based cohort of twins in Finland. Diabetologia.1992; 35:1060-1067.
Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P,Permutt MA,Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glu-cokinase definition of a subtype of diabetes mellitus. N Engl J Med.1993; 328(10):697-702.
Tattershall RB. Maturity-onset diabetes of the young (MODY) in Pickup and Williams. Textbook of Diabetes.1991; 1:246.
Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P. Non-sense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature.1992 356:721-722.
Gabbay K H. The Insulinopathies. N. Engl. J. Med.1980; 302:165-7.
Tattershall RB. Maturity-onset diabetes of the young (MODY) in Pickup and Williams. Textbook of Diabetes.1991; 1:246.
Molina JM, Cooper GIS, Leighton B, Olefsky JM. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes.1990; 39:260-5.
Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC. Cellular and humoural autoimmunity markers in Type 2 (non-insulin-dependent.) diabetic patients with secondary drug failure. Diabetologia.1992; 35:1159-1164.
Akinmokun A, Harris P, Home PD, Alberti KG. Is diabetes always diabetes? Diabetes Res. Clin. Pract.1992 18:131-136.
Bastaki S. Review Diabetes mellitus and its treatment.Int J Diabetes & Metabolism.2005;13: 111-134.
Piero MN. Hypoglycemic effects of some Kenyan plants traditionally used in management of diabetes mellitus in eastern province, Msc thesis, Kenyatta University.2006.
Henry RR, Gumbiner BN, Ditzler T. Intensive conventional insulin therapy for type II Diabetes. Metabolic effects during 6-month outpatient trial. Diabetes Care.1993;16: 21-31.
Kudlacek S, SchernthanerG. The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five-year follow-up study. HormMetabR.1992; 24: 478-483.
Yki-Jarvinen H, Ryysy L, Nikkilä K., Tulokas T,Vanamo R,HeikkilaM. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized trial. Ann Intern Med.1999; 130: 289-396.
Clarke BF, Duncan LJP. Biguanide treatment in the management of insulin dependent (maturity onset) diabetes: clinical experience with metformin. Res Clin Forums.1979;1: 53-63.
Sum CF, Webster JM, Johnson AB. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes. Diabet Metab.1992;9:61-65.
Carroll MF, Izard A, Riboni K. Control of postprandial hyperglycemia: optimal use of short?acting insulinsecretagogues. Diabetes Care. 2002; 25(12):2147?52.
Rosenstock J, Hassman DR, Madder RD. Repaglinide versus NateglinideMonotherapy: a randomized, multicenter study. Diabetes Care.2004; 27:1265?1270.
Colagiuri S, Cull CA, Holman RR, UKPDS Group: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Diabetes Care.2002; 25:1410?1417.
KamleshPP,Harsh MJ, FalgunidM, Varsha JP. Newer Approaches in the Treatment of Diabetes mellitus NH Journal of medical sciences .2013; 2.1:1-6.
Modak M, Dixit P, Londhe J. Devasagayam. Indian herbs and herbal drugs used for the treatment of diabetes. J ClinBiochem Nutr.2007;40: 163-73.
Kumar K, Fateh V, Verma B, Pandey S. Some Herbal Drugs Used For Treatment of DiabetesInterna-tional Journal of Research and Development in Pharmacy and Life Sciences.2014; 3(5):1116-1120.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
